Home/Filings/4/0001213900-17-000873
4//SEC Filing

DelMar Pharmaceuticals, Inc. 4

Accession 0001213900-17-000873

$HURACIK 0001498382operating

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 11:44 AM ET

Size

4.5 KB

Accession

0001213900-17-000873

Insider Transaction Report

Form 4
Period: 2017-02-01
BACHA JEFFREY
CEO and President10% Owner
Transactions
  • Purchase

    Common Stock

    2017-02-01$5.00/sh+4,000$20,00038,969 total

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001498382

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 11:44 AM ET
Size
4.5 KB